Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRDMT1 | O14717 | 3/20 | 0.75 |
| ▸ | DOT1L | Q8TEK3 | 5/20 | 0.70 |
| ▸ | PRMT1 | Q99873 | 3/20 | 0.68 |
| ▸ | CARM1 | Q86X55 | 2/20 | 0.68 |
| ▸ | EHMT2 | Q96KQ7 | 1/20 | 0.68 |
| ▸ | AHCY | P23526 | 2/20 | 0.63 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.60 |
| ▸ | DPP4 | P27487 | 1/20 | 0.60 |
| ▸ | MEN1 | O00255 | 1/20 | 0.60 |
| ▸ | SLC28A1 | O00337 | 1/20 | 0.60 |
| ▸ | MAP3K7 | O43318 | 1/20 | 0.60 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.60 |
| ▸ | GAPDH | P04406 | 1/20 | 0.60 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.60 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.60 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.60 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.60 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.60 |
| ▸ | STAT6 | P42226 | 1/20 | 0.60 |
| ▸ | PI4KA | P42356 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13986343 | 1.00 | TRDMT1 (0.75) | TRDMT1DOT1LPRMT1CARM1EHMT2 | |
| SCHEMBL13986353 | 0.92 | TRDMT1 (0.77) | TRDMT1DOT1LPRMT1CARM1AHCY | |
| SCHEMBL13986290 | 0.92 | TRDMT1 (0.77) | TRDMT1DOT1LPRMT1CARM1AHCY | |
| SCHEMBL13986348 | 0.82 | DOT1L (1.00) | TRDMT1DOT1LPRMT1CARM1EHMT2 | |
| SCHEMBL13986355 | 0.82 | DOT1L (1.00) | TRDMT1DOT1LPRMT1CARM1EHMT2 | |
| SCHEMBL17859778 | 0.82 | DOT1L (0.75) | DOT1LPRMT1CARM1AHCYKMT2A | |
| SCHEMBL20419303 | 0.81 | AHCY (0.77) | DOT1LAHCYKMT2ADPP4MEN1 | |
| SCHEMBL538530 | 0.80 | AHCY (0.80) | DOT1LAHCYKMT2ADPP4MEN1 | |
| SCHEMBL6297859 | 0.80 | AHCY (0.80) | DOT1LAHCYKMT2ADPP4MEN1 | |
| SCHEMBL538531 | 0.80 | AHCY (0.80) | DOT1LAHCYKMT2ADPP4MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8822146-B2 | Derivatization of biomolecules by covalent coupling of non-cofactor compounds using methyltransferases | VILNIUS UNIVERSITY (LT) | 2014-09-02 | — | — | US | disclosed |
| EP-2414528-B1 | DERIVATIZATION OF BIOMOLECULES BY COVALENT COUPLING OF NON-COFACTOR COMPOUNDS USING METHYLTRANSFERASES | UNIV VILNIUS (LT) | 2014-05-07 | — | — | EP | disclosed |
| US-20120094280-A1 | DERIVATIZATION OF BIOMOLECULES BY COVALENT COUPLING OF NON-COFACTOR COMPOUNDS USING METHYLTRANSFERASES | BIOTECHNOLOGIJOS INSTITUTAS (LT) | 2012-04-19 | — | — | US | disclosed |
| EP-2414528-A1 | DERIVATIZATION OF BIOMOLECULES BY COVALENT COUPLING OF NON-COFACTOR COMPOUNDS USING METHYLTRANSFERASES | Biotechnologijos Institutas (LT) | 2012-02-08 | — | — | EP | disclosed |
| WO-2010115846-A1 | DERIVATIZATION OF BIOMOLECULES BY COVALENT COUPLING OF NON-COFACTOR COMPOUNDS USING METHYLTRANSFERASES | BIOTECHNOLOGIJOS INSTITUTAS (LT) | 2010-10-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120094280-A1 | DERIVATIZATION OF BIOMOLECULES BY COVALENT COUPLING OF NON-COFACTOR COMPOUNDS USING METHYLTRANSFERASES | EZH1, DOHH, BHMT2 | TRDMT1 349/4885DOT1L 22/4885PRMT1 118/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.